Download PDF
Anästhesiol Intensivmed Notfallmed Schmerzther 2011; 46(10): 674-682
DOI: 10.1055/s-0031-1291946
Fachwissen
Anästhesie-Topthema: Perioperative Prophylaxe und Therapie von Infektionen
© Georg Thieme Verlag Stuttgart · New York

Perioperative Prophylaxe und Therapie von Infektionen – Perioperative Antibiotikaprophylaxe

Perioperative antimicrobial prophylaxis
Ina Tammer
,
Gernot Geginat
,
Dirk Schlüter
Further Information

Publication History

Publication Date:
21 October 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die perioperative Antibiotikaprophylaxe (PAP) stellt eine wichtige, jedoch nicht die alleinige Maßnahme zur Prävention postoperativer Wundinfektionen dar. Ihre Wirksamkeit wurde in einer Vielzahl von Studien belegt und in nationalen und internationalen Leitlinien umgesetzt. Neben der Auswahl des Antibiotikums sind Art, Dauer und Zeitpunkt der Applikation wichtige Kriterien für den Erfolg der Prophylaxe. Der Artikel gibt einen Überblick über die zur PAP empfohlenen Antibiotika und deren Einfluss auf das normalerweise zu erwartende Erregerspektrum bei elektiven Eingriffen. Darüber hinaus werden die häufigsten Problemkeime postoperativer Wundinfektionen und der derzeitige Stellenwert alternativer Antibiotika diskutiert.

Abstract

Perioperative antimicrobial prophylaxis (AMP) is an important but not the only procedure to prevent surgical site infections. The effectiveness of AMP to prevent surgical site infections has been proven in numerous studies during the last decades and is part of national and international guidelines. The choice of the antibiotic as well as the duration, time point and mode of application strongly impact on the effectiveness of the prophylaxis. This article provides an overview on recommended antibiotics for AMP and their activity against the expected bacterial pathogens in elective surgery. Furthermore, the current spectrum of microorganisms most frequently isolated from surgical site infections and alternative antibiotic strategies are discussed.

Kernaussagen

  • Nach wie vor ist die perioperative Antibiotikaprophylaxe mit Amino- / Azylaminopenizilline/BLI oder Cephalosporinen der 1./2. Generation ausreichend effektiv, was sich an den in Deutschland niedrigen postoperativen Wundinfektionsraten zeigt.

  • Bei Patienten mit nachgewiesenen Allergien gegen Beta-Lactam-Antibiotika muss auf alternative Substanzen wie Clindamycin oder Fluorochinolone (oder Vancomycin) zurückgegriffen werden.

  • Bei Hochrisikopatienten, antibiotisch vorbehandelten Patienten und Patienten mit Ableitungen muss man von einer Selektion resistenter Spezies ausgehen. Hier sollten Substanzen mit einem erweiterten Wirkspektrum gewählt werden.

  • Patienten mit einem erhöhten Risiko für eine MRSA-Kolonisation sollten vor elektiven Eingriffen auf MRSA gescreent und nach Möglichkeit präoperativ saniert werden. Ist eine Sanierung vorher nicht möglich, sollte die Dekolonisationsbehandlung perioperativ weitergeführt werden.

  • In operativen Einrichtungen mit niedriger MRSA-Prävalenz sollten weiterhin Amino- / Azylaminopenizilline/BLI-Kombinationen oder Cephalosporine der 1./2. Generation eingesetzt werden.

  • In operativen Einrichtungen mit hoher Prävalenz Methicillin-resistenter Staphylokokken und vorgesehener Implantation von Fremdmaterial kann eine zusätzliche perioperative Prophylaxe mit Vancomycin erwogen werden.

  • Das Antibiotikum sollte intravenös appliziert werden, um in kurzer Zeit ausreichend hohe Serum- und Gewebespiegel zu erreichen.

  • Optimal ist ein Zeitintervall von 1 h vor bis 2 h nach der Inzision, spätestens jedoch vor Wundverschluss. Sollen intraoperativ Materialien für die kulturelle mikrobiologische Diagnostik gewonnen werden, so darf das Antibiotikum erst nach Materialentnahme gegeben werden.

  • Bei Operationen, die länger als 2 h dauern, sollte eine Wiederholungsdosis gegeben werden.

  • Eine Verlängerung der perioperativen Prophylaxe über die Dauer der Operation hinaus reduziert postoperative Wundinfektionen nicht, sondern erhöht das Risiko für die Selektion resistenter Spezies. Außerdem steigt das Risiko für die Entstehung C. difficile-assoziierter Diarrhoen.

Schlüsselwörter:

perioperative Antibiotikaprophylaxe - Prävention - postoperative Wundinfektion - MRSA

Key words:

perioperative antimicrobial prophylaxis - prevention - surgical site infections - MRSA

Ergänzendes Material

 

  • Literatur

  • 1 Burke JP. Maximizing appropriate antibiotic prophylaxis for surgical patients: an update from LDS Hospital, Salt Lake City. Clin Infect Dis (Suppl. 02) 2001; 33
    PubMedGoogle Scholar
  • 2 Polk Jr. HC, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969; 66: 97-103
    PubMedGoogle Scholar
  • 3 Wacha H, Hoyme U, Isenmann R et al. Perioperative Antibiotikaprophylaxe. Chemother J 2010; 19: 70-84
    PubMedGoogle Scholar
  • 4 Mangram AJ, Horan TC, Pearson ML et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27: 97-132
    CrossrefPubMedGoogle Scholar
  • 5 Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg 2009; 249: 551-556
    CrossrefPubMedGoogle Scholar
  • 6 Nelson RL, Glenny AM, Song F. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev CD 001181 2009; 1
    PubMedGoogle Scholar
  • 7 Aufenacker TJ, Koelemay MJ, Gouma DJ, Simons MP. Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia. Br J Surg 2006; 93: 5-10
    CrossrefPubMedGoogle Scholar
  • 8 Cunningham M, Bunn F, Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev CD 005360 2006; 2
    PubMedGoogle Scholar
  • 9 Kappstein I, Daschner FD. Use of perioperative antibiotic prophylaxis in selected surgical procedures – results of a survey in 889 surgical departments in German hospitals. Infection 1991; 19: 391-394
    CrossrefPubMedGoogle Scholar
  • 10 Zur Entwicklung nosokomialer Infektionen im Krankenhausinfektions-Surveillance-System (KISS). Epidemiologisches Bulletin 2001; 5: 35-37
    PubMedGoogle Scholar
  • 11 Weiss III CA, Statz CL, Dahms RA et al. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999; 134: 10411048-10411048
    PubMedGoogle Scholar
  • 12 Olsen MA, Butler AM, Willers DM et al. Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol 2008; 29: 477-484
    CrossrefPubMedGoogle Scholar
  • 13 Tita AT, Owen J, Stamm AM et al. Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection. Am J Obstet Gynecol 2008; 199: 303-303
    PubMedGoogle Scholar
  • 14 Shannon K, Williams H, King A, Phillips I. Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15. FEMS Microbiol Lett 1990; 55: 319-323
    PubMedGoogle Scholar
  • 15 Campoli-Richards DM, Brogden RN. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs 1987; 33: 577-609
    CrossrefPubMedGoogle Scholar
  • 16 Bryson HM, Brogden RN. Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1994; 47: 506-535
    CrossrefPubMedGoogle Scholar
  • 17 Cephalosporine zur parenteralen Gabe. ZCT 2001; 22: 20-21
    PubMedGoogle Scholar
  • 18 Neumeister BH. Mikrobiologische Diagnostik. Stuttgart: Thieme; 2009
    Google Scholar
  • 19 Hahn HH. Medizinische Mikrobiologie und Infektiologie. Heidelberg: Springer; 2009
    CrossrefGoogle Scholar
  • 20 Wiedemann B, Heisig P. Bakterielle Resistenz gegenüber Chinolonen (Ciprofloxacin). Chemother J 1999; 99-108
    PubMedGoogle Scholar
  • 21 Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg 2011; 253: 1082-1093
    CrossrefPubMedGoogle Scholar
  • 22 Gradl G, Horn C, Postl LK et al. Antibiotic prophylaxis in primary and revision hip arthoplasty: what is the evidence?. Orthopade 2011; 40: 520-527
    PubMedGoogle Scholar
  • 23 Knebel P, Weigand MA, Buchler MW, Seiler CM. Evidence-based antibiotic prophylaxis in general and visceral surgery. Chirurg 2011; 82: 227-234
    CrossrefPubMedGoogle Scholar
  • 24 Stille WH. Antibiotika-Therapie. Stuttgart: Schattauer; 2005
    Google Scholar
  • 25 Lewis RT. Oral versus systemic antibiotic prophylaxis in elective colon surgery:a randomized study and meta-analysis send a message from the 1990s. Can J Surg 2002; 45: 173-180
    PubMedGoogle Scholar
  • 26 Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-168
    PubMedGoogle Scholar
  • 27 Rosin E, Ebert S, Uphoff TS et al. Penetration of antibiotics into the surgical wound in a canine model. Antimicrob Agents Chemother 1989; 33: 700-704
    CrossrefPubMedGoogle Scholar
  • 28 Luzzati R, Sanna A, Allegranzi B et al. Pharmacokinetics and tissue penetration of vancomycin in patients undergoing prosthetic mammary surgery. J Antimicrob Chemother 2000; 45: 243-245
    CrossrefPubMedGoogle Scholar
  • 29 DiPiro JT, Vallner JJ, Bowden Jr. TA et al. Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg 1985; 120: 829-832
    CrossrefPubMedGoogle Scholar
  • 30 Steinberg JP, Braun BI, Hellinger WC et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009; 250: 10-16
    CrossrefPubMedGoogle Scholar
  • 31 Zelenitsky SA, Ariano RE, Harding GK, Silverman RE. Antibiotic pharmaco-dynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 2002; 46: 3026-3030
    CrossrefPubMedGoogle Scholar
  • 32 Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106: 750-706
    PubMedGoogle Scholar
  • 33 Mertz D, Johnstone J, Loeb M. Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis. Ann Surg 2011; 254: 48-54
    CrossrefPubMedGoogle Scholar
  • 34 Suehiro T, Hirashita T, Araki S et al. Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery. Hepatogastroenterology 2008; 55: 1636-1639
    PubMedGoogle Scholar
  • 35 De Chiara S, Chiumello D, Nicolini R et al. Prolongation of antibiotic prophylaxis after clean and clean-contaminated surgery and surgical site infection. Minerva Anestesiol 2010; 76: 413-419
    PubMedGoogle Scholar
  • 36 Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-2921
    CrossrefPubMedGoogle Scholar
  • 37 de Lalla F, Privitera G, Ortisi G et al. Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital. J Antimicrob Chemother 623-631
    PubMedGoogle Scholar
  • 38 Carignan A, Allard C, Pepin J et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46: 1838-1843
    CrossrefPubMedGoogle Scholar
  • 39 Su HY, Ding DC, Chen DC et al. Prospective randomized comparison of single-dose versus 1-day cefazolin for prophylaxis in gynecologic surgery. Acta Obstet Gynecol Scand 2005; 84: 384-389
    PubMedGoogle Scholar
  • 40 Wertzel H, Swoboda L, Joos-Wurtemberger A et al. Perioperative antibiotic prophylaxis in general thoracic surgery. Thorac Cardiovasc Surg 1992; 40: 326-329
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Gillespie WJ, Walenkamp GH. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev CD 000244 2010; 3
    PubMedGoogle Scholar
  • 42 Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis 2001; 7: 828-831
    CrossrefPubMedGoogle Scholar
  • 43 Miliani K, L'Heriteau F, Astagneau P. Non-compliance with recommendations for the practice of antibiotic prophylaxis and risk of surgical site infection: results of a multilevel analysis from the INCISO Surveillance Network. J Antimicrob Chemother 2009; 64: 1307-1315
    CrossrefPubMedGoogle Scholar
  • 44 Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706-1715
    CrossrefPubMedGoogle Scholar
  • 45 Price CS, Williams A, Philipps G et al. Staphyloccocus areus nasal colonization in preoperative orthopaedic outpatients. Clin Orthop Relat Res 2008; 466: 2842-2847
    Google Scholar
  • 46 Kenner J, O'Connor T, Piantanida N et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003; 24: 439-439
    CrossrefPubMedGoogle Scholar
  • 47 Anderson DJ, Kaye KS, Chen LF et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS One 2009; 4
    PubMedGoogle Scholar
  • 48 Yano M, Doki Y, Inoue M et al. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000; 30: 16-21
    CrossrefPubMedGoogle Scholar
  • 49 Wilcox MH, Hall J, Pike H et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003; 54: 196-201
    CrossrefPubMedGoogle Scholar
  • 50 Coskun D, Aytac J. Decrease in Staphylococcus aureus surgical-site infection rates after orthopaedic surgery after intranasal mupirocin ointment. J Hosp Infect 2004; 58: 90-91
    CrossrefPubMedGoogle Scholar
  • 51 Prävention postoperativer Infektionen im Operationsgebiet. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2007; 50: 377-393
    PubMedGoogle Scholar
  • 52 Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 209-222
    CrossrefPubMedGoogle Scholar
  • 53 Saginur R, Croteau D, Bergeron MG. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group. J Thorac Cardiovasc Surg 2000; 120: 1120-1130
    CrossrefPubMedGoogle Scholar
  • 54 Bolon MK, Morlote M, Weber SG et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004; 38: 1357-1363
    CrossrefPubMedGoogle Scholar
  • 55 Garey KW, Amrutkar P, Dao-Tran TK et al. Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery. Pharmacotherapy 2008; 28: 699-706
    CrossrefPubMedGoogle Scholar
  • 56 Tacconelli E, Cataldo MA, Albanese A et al. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. J Hosp Infect 2008; 69: 337-344
    CrossrefPubMedGoogle Scholar
  • 57 Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995; 44: 1-13
    PubMedGoogle Scholar
  • 58 Murray PR, Baron E., Jorgensen JH et al. Manual of clinical microbiology. 9th edition. Washington DC: ASM Press; 2007
    Google Scholar
  • 59 Köhler W, Eggers HJ, Fleischer B et al. (Hrsg.) Medizinische Mikrobiologie. Aufl. München, Jena: Urban & Fischer; 2001. 8.
    Google Scholar
  • 60 http://www.awmf.org
    PubMed
  • 61 http://www.sfar.org/consensusantibio.html
    PubMed
  • 62 http://www.p-e-g.org/ag_resistenz/main.htm Bericht über die Ergebnisse der Studien aus dem Jahr. 2007
    PubMedGoogle Scholar